CIK 0001705843
- Non-accelerated filer
- Smaller reporting company
Cibus, Inc.
Sign in to watch- Ticker
- CBUS
- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271967997
- Phone
- +1 858-450-0008
- Business address
- 6455 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Former names
- Calyxt, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 15 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-01 | Voytas Daniel F Chief Science Officer | Exercise or conversion | +4,087 | $3.71 | $15K | 97,069 |
| 2019-02-01 | Voytas Daniel F Chief Science Officer | Sale | −4,087 | $13.00 | $53K | 92,982 |
| 2019-02-01 | Voytas Daniel F Chief Science Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,087 | 4,083 | ||
| 2019-01-31 | Voytas Daniel F Chief Science Officer | Exercise or conversion | +4,083 | $3.71 | $15K | 97,065 |
| 2019-01-31 | Voytas Daniel F Chief Science Officer | Sale | −4,083 | $13.00 | $53K | 92,982 |
| 2019-01-31 | Voytas Daniel F Chief Science Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,083 | 8,170 | ||
| 2019-01-04 | Dumont Philippe Director | Sale | −1,117 | $12.00 | $13K | 17,060 |
| 2019-01-02 | Sahoo Manoj Chief Commercial Officer | Sale | −2,444 | $10.39 | $25K | 76,669 |
| 2018-12-18 | Voytas Daniel F Chief Science Officer | Exercise or conversion | +4,083 | $3.71 | $15K | 97,065 |
| 2018-12-18 | Voytas Daniel F Chief Science Officer | Sale | −4,083 | $13.00 | $53K | 92,982 |
| 2018-12-18 | Voytas Daniel F Chief Science Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,083 | 12,253 | ||
| 2018-11-08 | Voytas Daniel F Chief Science Officer | Exercise or conversion | +4,083 | $3.71 | $15K | 97,065 |
| 2018-11-08 | Voytas Daniel F Chief Science Officer | Sale | −4,083 | $13.00 | $53K | 92,982 |
| 2018-11-08 | Voytas Daniel F Chief Science Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,083 | 16,336 | ||
| 2018-10-09 | Voytas Daniel F Chief Science Officer | Exercise or conversion | +4,083 | $3.71 | $15K | 97,065 |
| 2018-10-09 | Voytas Daniel F Chief Science Officer | Sale | −4,083 | $13.84 | $57K | 92,982 |
| 2018-10-09 | Voytas Daniel F Chief Science Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,083 | 20,419 | ||
| 2018-10-08 | NEUGENT CHRISTOPHER J Director | Grant or award | +19,600 | 19,600 | ||
| 2018-10-08 | NEUGENT CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +29,400 | 29,400 | ||
| 2018-10-08 | Jonathan Fassberg Director | Grant or award | +19,600 | 19,600 |
Page 24 of 27 · 525 trades